Long-term motor cortex stimulation for amyotrophic lateral sclerosis

Brain Stimulation

Volumn 3, Issue 1, 2010, Pages 22-27

  Di Lazzaro, Vincenzo ^a,b   Dileone, Michele ^a,b   Pilato, Fabio ^a   Profice, Paolo ^a   Cioni, Beatrice ^c   Meglio, Mario ^c   Papacci, Fabio ^c   Sabatelli, Mario ^a   Musumeci, Gabriella ^a   Ranieri, Federico ^a   Tonali, Pietro A ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

ALS; epidural motor cortex stimulation; motor cortex; transcranial magnetic stimulation

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BICEPS BRACHII MUSCLE; CASE REPORT; DETERIORATION; DISEASE COURSE; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL RESEARCH; MOTOR CORTEX; PRIORITY JOURNAL; TIBIALIS ANTERIOR MUSCLE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 75149176175     PISSN: 1935861X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brs.2009.04.004     Document Type: Article

References (37)

1. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 344 (2001) 1688-1700
2. Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65 Suppl 1 (2009) S3-S9
3. Di Lazzaro V., Oliviero A., Profice P., et al. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. J Physiol 547 (2003) 485-496
4. Ridding M.C., and Rothwell J.C. Is there a future for therapeutic use of transcranial magnetic stimulation?. Nature Rev 8 (2007) 559-567
5. Di Lazzaro V., Oliviero A., Saturno E., et al. Motor cortex stimulation for amyotrophic lateral sclerosis: time for a therapeutic trial?. Clin Neurophysiol 115 (2004) 1479-1485
6. Di Lazzaro V., Dileone M., Pilato F., et al. Repetitive transcranial magnetic stimulation for ALS. A preliminary controlled study. Neurosci Lett 408 (2006) 135-140
7. Ziemann U., and Eisen A. TMS for ALS: why and why not. Clin Neurophysiol 115 (2004) 1237-1238
8. Sidoti C., and Agrillo U. Chronic cortical stimulation for amyotropic lateral sclerosis: a report of four consecutive operated cases after a 2-year follow-up: technical case report. Neurosurgery 58 (2006) E384 discussion E384
9. Drouot X., Nguyen J.P., Peschanski M., and Lefaucheur J.P. The antalgic efficacy of chronic motor cortex stimulation is related to sensory changes in the painful zone. Brain 125 (2002) 1660-1664
10. Canavero S., Bonicalzi V., Paolotti R., et al. Therapeutic extradural cortical stimulation for movement disorders: a review. Neurol Res 25 (2003) 118-122
11. Lefaucheur J.P. Principles of therapeutic use of transcranial and epidural cortical stimulation. Clin Neurophysiol 119 (2008) 2179-2184
12. Di Lazzaro V., Oliviero A., Pilato F., et al. Comparison of descending volleys evoked by transcranial and epidural motor cortex stimulation in a conscious patient with bulbar pain. Clin Neurophysiol 115 (2004) 834-838
13. Huang Y.Z., Edwards M.J., Rounis E., Bhatia K.P., and Rothwell J.C. Theta burst stimulation of the human motor cortex. Neuron 45 (2005) 201-206
14. Di Lazzaro V., Pilato F., Saturno E., et al. Theta-burst repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex. J Physiol 565 (2005) 945-950
15. Brooks B.R., Miller R.G., Swash M., and Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (2000) 293-299
16. Floyd A.G., Yu Q.P., Piboolnurak P., et al. Transcranial magnetic stimulation in ALS: utility of central motor conduction tests. Neurology 72 (2009) 498-504
17. Chen R., Classen J., Gerloff C., et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 48 (1997) 1398-1403
18. Di Lazzaro V., Pilato F., Dileone M., et al. Low-frequency repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex. J Physiol 586 (2008) 4481-4487
19. Cioni B. Motor cortex stimulation for Parkinson's disease. Acta Neurochir Suppl 97 (2007) 233-238
20. Cioni B., Meglio M., Perotti V., De Bonis P., and Montano N. Neurophysiological aspects of chronic motor cortex stimulation. Neurophysiol Clin 37 (2007) 441-447
21. Rothstein J.D., Tsai G., Kuncl R.W., et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28 (1990) 18-25
22. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38 (1995) 73-84
23. Brooks B.R. Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life. Ann Neurol 65 Suppl 1 (2009) S17-S23
24. de Carvalho M., Costa J., and Swash M. Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements. Amyotroph Lateral Scler Other Motor Neuron Disord 6 (2005) 202-212
25. Gordon P.H., Moore D.H., Miller R.G., et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6 (2007) 1045-1053
26. Zhu S., Stavrovskaya I.G., Drozda M., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78
27. Traynor B.J., Zhang H., Shefner J.M., Schoenfeld D., and Cudkowicz M.E. Functional outcome measures as clinical trial endpoints in ALS. Neurology 63 (2004) 1933-1935
28. Mills K.R. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain 126 (2003) 2558-2566
29. Rothstein J.D., Martin L.J., and Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326 (1992) 1464-1468
30. Caramia M.D., Palmieri M.G., Desiato M.T., et al. Pharmacologic reversal of cortical hyperexcitability in patients with ALS. Neurology 54 (2000) 58-64
31. Desiato M.T., Palmieri M.G., Giacomini P., Scalise A., Arciprete F., and Caramia M.D. The effect of riluzole in amyotrophic lateral sclerosis: a study with cortical stimulation. J Neurol Sci 169 (1999) 98-107
32. Liepert J., Schwenkreis P., Tegenthoff M., and Malin J.P. The glutamate antagonist riluzole suppresses intracortical facilitation. J Neural Transm 104 (1997) 1207-1214
33. Schwenkreis P., Liepert J., Witscher K., et al. Riluzole suppresses motor cortex facilitation in correlation to its plasma level: a study using transcranial magnetic stimulation. Exp Brain Res 135 (2000) 293-299
34. Sommer M., Tergau F., Wischer S., Reimers C.D., Beuche W., and Paulus W. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis. J Neurol 246 Suppl 3 (1999) III22-III26
35. Stefan K., Kunesch E., Benecke R., and Classen J. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol 49 (2001) 536-539
36. Ziemann U., Winter M., Reimers C.D., Reimers K., Tergau F., and Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis: evidence from paired transcranial magnetic stimulation. Neurology 49 (1997) 1292-1298
37. Vucic S., and Kiernan M.C. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 129 (2006) 2436-2446